Laddar...
An uncontrolled trial of cytisine (Tabex) for smoking cessation
OBJECTIVES: Cytisine (Tabex) has been licensed in Eastern Europe as an aid to smoking cessation for 40 years. Cytisine is a partial agonist with high affinity binding to the α4β2 nicotinic acetylcholine receptor believed to be central to the rewarding effect of nicotine. There is insufficient inform...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Group
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2563682/ https://ncbi.nlm.nih.gov/pubmed/17130378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tc.2006.016097 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|